ATN 064: IMMUNOGENICITY, SAFETY, TOLERABILITY, AND BEHAVIORAL CONSEQUENCES OF

ATN 064：免疫原性、安全性、耐受性和行为后果

• 批准号: 8167298
• 负责人: LAWRENCE James D'ANGELO
• 金额: $ 0.63万
• 依托单位: CHILDREN'S RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-01-20 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8167298
• 关键词: Behavioral; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Human Papilloma Virus Vaccine; Institution; Phase; Research; Research Personnel; Resources; Safety; Source; United States National Institutes of Health; Vaccination; Woman; immunogenic; immunogenicity; open label; risk perception; sex risk

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objectives of this phase II, open-label, multi-center study are to determine whether the quadrivalent HPV vaccine is immunogenic, safe, and well-tolerated in 16- to 23-year-old HIV-infected young women, and to examine whether vaccination impacts their perceptions of risk and sexual behaviors.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 该第二阶段，开放标签的多中心研究的目标是确定在16至23岁的感染HIV的年轻妇女中，四相的HPV疫苗具有免疫原性，安全和耐受性，并检查疫苗是否影响其对风险和性行为的看法。